Listed

TherapeuticsMD, Inc.

TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31

Reports and events: 392 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

TherapeuticsMD, Inc., Reports and events
FiledFormWhat it isAccession number
2023-04-0716:46 ET10-KAnnual reportPeriod 2022-12-310001564590-23-005514
2023-04-0716:41 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-095317
2023-02-2716:27 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-050813
2023-01-1817:00 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-010258
2023-01-1217:01 ET8-K3.01 Delisting notice0001193125-23-007281
2023-01-0617:30 ET8-K/A5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-003686
2023-01-0307:00 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-000222
2022-12-0507:31 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-298002
2022-12-0109:23 ET8-K1.01 Entry into a material agreement0001193125-22-296035
2022-11-1417:03 ET10-QQuarterly reportPeriod 2022-09-300001564590-22-037666
2022-11-1416:24 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-037633
2022-10-3107:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-273110
2022-10-0307:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-256102
2022-09-1207:01 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-242398
2022-08-3009:09 ETSC 13D/AOwnership report, active investor, amended0001104659-22-095856
2022-08-2917:01 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-232894
2022-08-1516:21 ET10-QQuarterly reportPeriod 2022-06-300001564590-22-029490
2022-08-1507:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-029394
2022-08-0816:42 ETSC 13DOwnership report, active investor0001104659-22-087294
2022-08-0106:55 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-207645
2022-07-2908:58 ET8-K1.01 Entry into a material agreement0001193125-22-205794
2022-07-2809:47 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-22-204332
2022-07-2508:00 ET8-K1.01 Entry into a material agreement; 8.01 Other events0001193125-22-200476
2022-07-1409:00 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001193125-22-193376
2022-06-0606:03 ET8-K/A5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001564590-22-022527
2022-06-0316:31 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001564590-22-022465
2022-05-3106:47 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001564590-22-021755
2022-05-2010:30 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001564590-22-020824
2022-05-1617:03 ET10-QQuarterly reportPeriod 2022-03-310001564590-22-020440
2022-05-1616:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-020389
2022-05-0906:30 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001564590-22-018687
2022-04-2916:26 ET10-K/AAnnual report, amendedPeriod 2021-12-310001564590-22-016823
2022-04-2716:30 ET8-K8.01 Other events0001564590-22-016083
2022-04-2016:20 ET8-K2.01 Completion of an acquisition or disposition; 2.04 Item not in the standard list; 9.01 Financial statements and exhibits0001564590-22-014927
2022-04-1416:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-014472
2022-03-2316:54 ET10-KAnnual reportPeriod 2021-12-310001564590-22-011525
2022-03-2316:17 ETSC 13D/AOwnership report, active investor, amended0001387131-22-003889
2022-03-1817:01 ET8-K3.01 Delisting notice; 5.02 Departure or appointment of officers or directors0001564590-22-011090
2022-03-1007:15 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-009476
2022-03-0707:47 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-008860
2022-02-1816:30 ET8-K5.02 Departure or appointment of officers or directors0001564590-22-005710
2022-01-0306:03 ET8-K8.01 Other events0001564590-22-000008
2021-12-2008:45 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-060676
2021-12-1717:00 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-060654
2021-12-1017:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001564590-21-060036
2021-12-0806:55 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001564590-21-059685
2021-11-1606:30 ET8-K/A2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-057142
2021-11-1206:55 ET10-QQuarterly reportPeriod 2021-09-300001564590-21-056434
2021-11-1206:47 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-056427
2021-10-0117:01 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-049852

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.